These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 34146401)
1. Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer. Chaudhary N; Choudhary BS; Shah SG; Khapare N; Dwivedi N; Gaikwad A; Joshi N; Raichanna J; Basu S; Gurjar M; P K S; Saklani A; Gera P; Ramadwar M; Patil P; Thorat R; Gota V; Dhar SK; Gupta S; Das M; Dalal SN Int J Cancer; 2021 Oct; 149(7):1495-1511. PubMed ID: 34146401 [TBL] [Abstract][Full Text] [Related]
2. TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer. Ren Y; Deng R; Cai R; Lu X; Luo Y; Wang Z; Zhu Y; Yin M; Ding Y; Lin J Carcinogenesis; 2020 Dec; 41(12):1755-1766. PubMed ID: 32338281 [TBL] [Abstract][Full Text] [Related]
3. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer. Zhao Y; Wang C; Goel A Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896 [TBL] [Abstract][Full Text] [Related]
4. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer. Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer. Zhang Y; Talmon G; Wang J Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730 [TBL] [Abstract][Full Text] [Related]
6. CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis. Lai Q; Li Q; He C; Fang Y; Lin S; Cai J; Ding J; Zhong Q; Zhang Y; Wu C; Wang X; He J; Liu Y; Yan Q; Li A; Liu S Aging (Albany NY); 2020 Jul; 12(16):16270-16293. PubMed ID: 32688344 [TBL] [Abstract][Full Text] [Related]
7. MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells. Zhang H; Tang J; Li C; Kong J; Wang J; Wu Y; Xu E; Lai M Cancer Lett; 2015 Jan; 356(2 Pt B):781-90. PubMed ID: 25449431 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway. Zhang W; Pan R; Lu M; Zhang Q; Lin Z; Qin Y; Wang Z; Gong S; Lin H; Chong S; Lu L; Liao W; Lu X Oncogene; 2021 Nov; 40(45):6369-6380. PubMed ID: 34588619 [TBL] [Abstract][Full Text] [Related]
9. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma. Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493 [TBL] [Abstract][Full Text] [Related]
10. RING-finger protein 6 promotes colorectal tumorigenesis by transcriptionally activating SF3B2. Xu H; Wong CC; Li W; Zhou Y; Li Y; Wang L; Liu L; Yu J Oncogene; 2021 Nov; 40(47):6513-6526. PubMed ID: 34611311 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer. Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-215-3p sensitizes colorectal cancer to 5-fluorouracil induced apoptosis through regulating CXCR1. Li XW; Qiu SJ; Zhang X Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7240-7250. PubMed ID: 30468467 [TBL] [Abstract][Full Text] [Related]
13. LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells. Zhang S; Zheng F; Zhang L; Huang Z; Huang X; Pan Z; Chen S; Xu C; Jiang Y; Gu S; Zhao C; Zhang Q; Shi G J Exp Clin Cancer Res; 2020 Jul; 39(1):131. PubMed ID: 32653028 [TBL] [Abstract][Full Text] [Related]
14. Plakophilin3 loss leads to increased adenoma formation and rectal prolapse in APC Raghavan R; Koyande N; Beher R; Chetlangia N; Ramadwar M; Pawade S; Thorat R; van Hengel J; Sklyarova T; van Roy F; Dalal SN Biochem Biophys Res Commun; 2022 Jan; 586():14-19. PubMed ID: 34823217 [TBL] [Abstract][Full Text] [Related]
15. Angiogenesis is promoted by exosomal DPP4 derived from 5-fluorouracil-resistant colon cancer cells. Zheng X; Liu J; Li X; Tian R; Shang K; Dong X; Cao B Cancer Lett; 2021 Jan; 497():190-201. PubMed ID: 33039561 [TBL] [Abstract][Full Text] [Related]
16. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation. Zhang L; Zhou R; Zhang W; Yao X; Li W; Xu L; Sun X; Zhao L J Exp Clin Cancer Res; 2019 Mar; 38(1):120. PubMed ID: 30850009 [TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathway. Yu Z; Zhang C; Wang H; Xing J; Gong H; Yu E; Zhang W; Zhang X; Cao G; Fu C Cancer Lett; 2014 Oct; 353(2):182-93. PubMed ID: 25088576 [TBL] [Abstract][Full Text] [Related]
18. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10. Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179 [TBL] [Abstract][Full Text] [Related]
20. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells. Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]